BRPI0816587A2 - Composição de pellet de ácido lipóico, uso de uma composição e unidade de dosagem - Google Patents

Composição de pellet de ácido lipóico, uso de uma composição e unidade de dosagem

Info

Publication number: BRPI0816587A2
Authority: BR; Brazil
Prior art keywords: composition; lipoic acid; dosing unit; acid pellet; pellet composition
Prior art date: 2007-10-23

Application number

BRPI0816587-4A2A

Other languages

English (en)

Inventor

Paolo Magri

Antonio Nardi

Annibale Salvi

Flavio Villani

Original Assignee

Laboratorio Chimico Int Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-23

Filing date

2008-10-23

Publication date

2015-03-03

2008-10-23 Application filed by Laboratorio Chimico Int Spa filed Critical Laboratorio Chimico Int Spa

2015-03-03 Publication of BRPI0816587A2 publication Critical patent/BRPI0816587A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Botany (AREA)
Biochemistry (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fodder In General (AREA)
Meat, Egg Or Seafood Products (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

BRPI0816587-4A2A 2007-10-23 2008-10-23 Composição de pellet de ácido lipóico, uso de uma composição e unidade de dosagem BRPI0816587A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002051A ITMI20072051A1 (it)	2007-10-23	2007-10-23	Composizione a base di pellet di acido lipoico
PCT/IB2008/002835 WO2009053824A1 (en)	2007-10-23	2008-10-23	Lipoic acid pellet composition

Publications (1)

Publication Number	Publication Date
BRPI0816587A2 true BRPI0816587A2 (pt)	2015-03-03

Family

ID=40313864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816587-4A2A BRPI0816587A2 (pt)	2007-10-23	2008-10-23	Composição de pellet de ácido lipóico, uso de uma composição e unidade de dosagem

Country Status (27)

Country	Link
US (1)	US9820948B2 (pt)
EP (1)	EP2217220B1 (pt)
JP (1)	JP5626890B2 (pt)
KR (1)	KR101599078B1 (pt)
CN (1)	CN101861144B (pt)
AT (1)	ATE506053T1 (pt)
AU (1)	AU2008315667B2 (pt)
BR (1)	BRPI0816587A2 (pt)
CA (1)	CA2703152C (pt)
CY (1)	CY1112122T1 (pt)
DE (1)	DE602008006454D1 (pt)
DK (1)	DK2217220T3 (pt)
ES (1)	ES2363880T3 (pt)
HR (1)	HRP20110453T1 (pt)
IL (1)	IL205211A (pt)
IT (1)	ITMI20072051A1 (pt)
MX (1)	MX2010004481A (pt)
NZ (1)	NZ584884A (pt)
PL (1)	PL2217220T3 (pt)
PT (1)	PT2217220E (pt)
RS (1)	RS51712B (pt)
RU (1)	RU2501558C2 (pt)
SI (1)	SI2217220T1 (pt)
TN (1)	TN2010000163A1 (pt)
UA (1)	UA100394C2 (pt)
WO (1)	WO2009053824A1 (pt)
ZA (1)	ZA201002777B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2537081B2 (ja)	1988-10-18	1996-09-25	富士写真フイルム株式会社	磁気記録媒体
GB0818473D0 (en)	2008-10-08	2008-11-12	Probio Nutraceuticals As	Composition
WO2011099031A1 (en)	2010-02-11	2011-08-18	Zota Health Care Limited	Active antioxidants for all age group
GB201006200D0 (en) *	2010-04-14	2010-06-02	Ayanda As	Composition
US20130045273A1 (en) *	2011-08-19	2013-02-21	John Cuomo	Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
US11337960B2 (en)	2014-10-24	2022-05-24	Pre-D Partners Llc	Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
EP3593795B1 (en) *	2016-12-14	2025-11-12	Cidat, S.A. De C.V.	Combinations and methods for the treatment of neuropathic pain
CN106729725A (zh) *	2017-03-21	2017-05-31	北京百慧生化制药有限责任公司	硫辛酸作为抗氧化剂在多烯酸乙酯制剂或蛹油α‑亚麻酸乙酯制剂中的应用
IT202200007232A1 (it) *	2022-04-12	2023-10-12	Uriach Italy S R L	Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
WO2023199241A1 (en) *	2022-04-12	2023-10-19	URIACH ITALY S.r.l.	Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0774166B2 (ja) *	1987-02-06	1995-08-09	信越化学工業株式会社	徐放性被覆薬剤の製造方法
US6197340B1 (en) *	1998-05-28	2001-03-06	Medical Research Institute	Controlled release lipoic acid
US6479069B1 (en) *	1999-09-23	2002-11-12	Juvenon, Inc.	Nutritional supplement for increased energy and stamina
US20020098247A1 (en) *	2000-11-02	2002-07-25	Komorowski James R.	Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
ITMI20012732A1 (it) *	2001-12-20	2003-06-20	Health Pharma S R L	Integratore alimentare per neuropatici
US20060193789A1 (en) *	2002-10-25	2006-08-31	Foamix Ltd.	Film forming foamable composition
CN1694695A (zh) *	2002-11-07	2005-11-09	帝斯曼知识产权资产管理有限公司	包含表没食子儿茶素没食子酸酯的新颖的营养药物性组合物
US7387793B2 (en) *	2003-11-14	2008-06-17	Eurand, Inc.	Modified release dosage forms of skeletal muscle relaxants
US20050181047A1 (en) *	2004-02-18	2005-08-18	Jaime Romero	Compositions and methods for timed release of water-soluble nutritional supplements
US20060182729A1 (en)	2005-02-17	2006-08-17	Prasad Kedar N	Combat/training antioxidant micronutrient formulation and method of administration
JP2006298831A (ja) *	2005-04-21	2006-11-02	Sumitomo Shoji Chemicals Co Ltd	αリポ酸粉体被覆物及びその製造方法、並びにαリポ酸含有食品
JP5157001B2 (ja) *	2005-04-30	2013-03-06	ビーエイチエヌ株式会社	安定化α−リポ酸組成物及びその利用
US20060270625A1 (en) *	2005-05-13	2006-11-30	Eastern Virginia Medical School	Nutraceuticals for the treatment of neuropathy
WO2007032340A1 (ja) *	2005-09-12	2007-03-22	Kyowa Hakko Kogyo Co., Ltd.	α－リポ酸含有組成物
WO2007123284A1 (en) *	2006-04-26	2007-11-01	Dpi Solutions, Inc.	Alpha lipoic acid capsule composition stabilized in water phase and method for preparing the same
ITMI20061024A1 (it) *	2006-05-25	2007-11-26	Eurand Pharmaceuticals Ltd	Pellet a base di acido lipoico

2007
- 2007-10-23 IT IT002051A patent/ITMI20072051A1/it unknown
2008
- 2008-10-23 MX MX2010004481A patent/MX2010004481A/es active IP Right Grant
- 2008-10-23 KR KR1020107010844A patent/KR101599078B1/ko not_active Expired - Fee Related
- 2008-10-23 US US12/739,449 patent/US9820948B2/en not_active Expired - Fee Related
- 2008-10-23 ES ES08840866T patent/ES2363880T3/es active Active
- 2008-10-23 CA CA2703152A patent/CA2703152C/en not_active Expired - Fee Related
- 2008-10-23 NZ NZ584884A patent/NZ584884A/en not_active IP Right Cessation
- 2008-10-23 DK DK08840866.1T patent/DK2217220T3/da active
- 2008-10-23 PL PL08840866T patent/PL2217220T3/pl unknown
- 2008-10-23 AT AT08840866T patent/ATE506053T1/de active
- 2008-10-23 BR BRPI0816587-4A2A patent/BRPI0816587A2/pt not_active IP Right Cessation
- 2008-10-23 RS RS20110249A patent/RS51712B/sr unknown
- 2008-10-23 WO PCT/IB2008/002835 patent/WO2009053824A1/en not_active Ceased
- 2008-10-23 JP JP2010530581A patent/JP5626890B2/ja not_active Expired - Fee Related
- 2008-10-23 PT PT08840866T patent/PT2217220E/pt unknown
- 2008-10-23 RU RU2010120706/15A patent/RU2501558C2/ru not_active IP Right Cessation
- 2008-10-23 CN CN2008801173655A patent/CN101861144B/zh not_active Expired - Fee Related
- 2008-10-23 SI SI200830241T patent/SI2217220T1/sl unknown
- 2008-10-23 HR HR20110453T patent/HRP20110453T1/hr unknown
- 2008-10-23 UA UAA201006077A patent/UA100394C2/ru unknown
- 2008-10-23 DE DE602008006454T patent/DE602008006454D1/de active Active
- 2008-10-23 EP EP08840866A patent/EP2217220B1/en active Active
- 2008-10-23 AU AU2008315667A patent/AU2008315667B2/en not_active Ceased
2010
- 2010-04-15 TN TN2010000163A patent/TN2010000163A1/fr unknown
- 2010-04-20 ZA ZA2010/02777A patent/ZA201002777B/en unknown
- 2010-04-21 IL IL205211A patent/IL205211A/en not_active IP Right Cessation
2011
- 2011-07-11 CY CY20111100670T patent/CY1112122T1/el unknown

Also Published As

Publication number	Publication date
CA2703152C (en)	2016-02-23
PL2217220T3 (pl)	2011-09-30
JP5626890B2 (ja)	2014-11-19
SI2217220T1 (sl)	2011-06-30
IL205211A (en)	2013-01-31
EP2217220A1 (en)	2010-08-18
HRP20110453T1 (hr)	2011-07-31
CN101861144A (zh)	2010-10-13
CN101861144B (zh)	2013-03-13
AU2008315667A1 (en)	2009-04-30
NZ584884A (en)	2011-11-25
DK2217220T3 (da)	2011-08-01
PT2217220E (pt)	2011-07-13
CY1112122T1 (el)	2015-11-04
JP2011500784A (ja)	2011-01-06
ZA201002777B (en)	2011-06-29
ES2363880T3 (es)	2011-08-18
US9820948B2 (en)	2017-11-21
EP2217220B1 (en)	2011-04-20
ATE506053T1 (de)	2011-05-15
DE602008006454D1 (de)	2011-06-01
IL205211A0 (en)	2010-12-30
TN2010000163A1 (en)	2011-11-11
UA100394C2 (en)	2012-12-25
RU2501558C2 (ru)	2013-12-20
MX2010004481A (es)	2010-08-02
AU2008315667B2 (en)	2013-02-28
ITMI20072051A1 (it)	2009-04-24
RU2010120706A (ru)	2011-11-27
RS51712B (sr)	2011-10-31
CA2703152A1 (en)	2009-04-30
WO2009053824A1 (en)	2009-04-30
US20110129442A1 (en)	2011-06-02
KR20100089848A (ko)	2010-08-12
KR101599078B1 (ko)	2016-03-02

Publication	Publication Date	Title
BRPI0816587A2 (pt)	2015-03-03	Composição de pellet de ácido lipóico, uso de uma composição e unidade de dosagem
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
EA200802184A1 (ru)	2009-06-30	Фармацевтические композиции с ингибиторами dpp iv
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BRPI0814031A2 (pt)	2014-10-14	Composições antimicrobianas de ácido peroxicarboxílico prontas para o uso, com corrosão reduzida, estáveis em prateleira.
UY33397A (es)	2011-12-01	Forma sólida de un naftaleno carboxamida
CL2011001497A1 (es)	2011-09-30	Compuestos derivados de heterociclos, modulador de gpr120; composicion farmaceutica; y su uso para el tratamiento de diabetes tipo i,ii y sindrome metabolico.
BRPI0913447A2 (pt)	2015-12-01	composição de éster, e, composição para cuidado pessoal.
DE602007012354D1 (de)	2011-03-17	Medizinisches abgabeystem mit drehbarem verschlüsselungselement
BRPI1014034A2 (pt)	2016-04-12	formulação e seu uso, composição, solução injetável e kit.
ECSP109852A (es)	2010-02-26	Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
BRPI0922435A2 (pt)	2018-09-11	"composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
EP2657333A4 (en)	2014-11-12	PIG CIRCOVIRUS OF TYPE 2, IMMUNA COMPOSITION THEREOF, TESTKIT AND USE THEREOF
CL2009000393A1 (es)	2010-01-04	Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
NO343776B1 (no)	2019-06-03	Forbindelse som modulerer farmakokinetikkegenskaper til terapeutika, dens anvendelse i terapi og farmasøytisk sammensetning derav.
CL2007002017A1 (es)	2008-06-13	Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
BRPI0912229A2 (pt)	2017-05-23	mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
BRPI0615900A2 (pt)	2016-08-23	granulados de enzima, uso de um granulado de enzima, e, ração
BRPI0911772A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso do composto.
BRPI0813587A2 (pt)	2014-12-30	Composto, uso do mesmo, e, composição farmacêutica
GT200600097A (es)	2006-11-13	Formas farmaceuticas con propiedades farmacocineticas mejoradas
BRPI0923642A2 (pt)	2016-01-19	dispositivo de dosagem para gerar um fluxo de gás com uma substância ativa finamente dispersada no último.
EA200601759A1 (ru)	2007-04-27	Композиции рамиприла
BRPI0716425A2 (pt)	2013-12-03	Nucleosídeos, fármacos contendo estes e uso destes
BR112012002311A2 (pt)	2016-05-31	composto, composição farmacêutica, e, uso do composto.

Legal Events

Date	Code	Title	Description
2018-03-20	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-08-20	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-08-27	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 11A ANUIDADE.
2019-12-17	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.